Subcutaneously administered systemic therapies are expected to reduce administration times, minimizing the time an individual treatment chair or room is needed while simultaneously giving patients the freedom to choose how to spend more of their…
Subcutaneous Pembrolizumab Shows Possibility of Providing Effective and Convenient Treatment in Oncology
